TREATMENT OF ADVANCED PARKINSON DISEASE WITH PERGOLIDE

被引:99
作者
LIEBERMAN, A
GOLDSTEIN, M
LEIBOWITZ, M
NEOPHYTIDES, A
KUPERSMITH, M
PACT, V
KLEINBERG, D
机构
[1] NYU, SCH MED, DEPT NEUROL, NEW YORK, NY 10003 USA
[2] NYU, SCH MED, DEPT NEUROCHEM, NEW YORK, NY 10003 USA
[3] NYU, SCH MED, DIV CARDIOL, NEW YORK, NY 10003 USA
[4] NYU, SCH MED, DIV ENDOCRINOL, NEW YORK, NY 10003 USA
关键词
D O I
10.1212/WNL.31.6.675
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:675 / 682
页数:8
相关论文
共 74 条
[1]   HYPERACTIVITY OF REMAINING DOPAMINERGIC NEURONS AFTER PARTIAL DESTRUCTION OF NIGRO-STRIATAL DOPAMINERGIC SYSTEM IN RAT [J].
AGID, Y ;
JAVOY, F ;
GLOWINSKI, J .
NATURE-NEW BIOLOGY, 1973, 245 (144) :150-151
[2]   CHEMICAL OR ELECTROLYTIC LESION OF SUBSTANTIA NIGRA - EARLY EFFECTS ON NEOSTRIATAL DOPAMINE METABOLISM [J].
AGID, Y ;
JAVOY, F ;
GLOWINSKI, J .
BRAIN RESEARCH, 1974, 74 (01) :41-49
[3]   A CLINICAL DISABILITY RATING FOR PARKINSON PATIENTS [J].
ALBA, A ;
TRAINOR, FS ;
RITTER, W ;
DACSO, MM .
JOURNAL OF CHRONIC DISEASES, 1968, 21 (07) :507-&
[4]   6 YEARS OF HIGH-LEVEL LEVODOPA THERAPY IN SEVERELY AKINETIC PARKINSONIAN PATIENTS [J].
BARBEAU, A .
ARCHIVES OF NEUROLOGY, 1976, 33 (05) :333-338
[5]   6-YEAR RESULTS OF TREATMENT WITH LEVODOPA PLUS BENZERAZIDE IN PARKINSONS-DISEASE [J].
BARBEAU, A ;
ROY, M .
NEUROLOGY, 1976, 26 (05) :399-404
[6]  
BARBEAU A, 1971, RECENT ADV PARKINSON, P204
[7]  
BARBEAU A, 1976, ADV PARKINSONISM, P424
[8]  
BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5
[9]   DEVELOPMENTS IN PHARMACOLOGY AND THERAPEUTICS OF PARKINSONISM [J].
CALNE, DB .
ANNALS OF NEUROLOGY, 1977, 1 (02) :111-119
[10]  
CALNE DB, 1978, LANCET, V1, P735